Abstract:Objective:To review the surgical approaches and mid-term outcomes of congenital mitral valve diseases in children.Methods:From January 2009 to December 2017, retrospective review was performed for 92 children undergoing mitral valvuloplasty for mitral stenosis (n=26) and mitral regurgitation (n=66). There were 44 boys and 48 girls with an average operative age of (42.55±40.57)(1-168) months. And 21/92(22.8%) were aged under 1 year.Results:Four cases (4.3%) died within an early stage of operation and 3 cases(3.3%) passed away during follow-ups. The total mortality rate was 7.6%. The grade of cardiac function improved significantly in all the children after surgery, including 3 patients with grade Ⅲ, and the rest were grade Ⅱ or above. During a follow-up period of (42.72±29.66)(3-104) months, 11 children (12.0%) underwent 17 reoperations. Log Rank analysis revealed that no significant inter-group difference existed in death or reoperation. Children aged under 1 year had higher mortality and rate of reoperation than those aged over 1 year ( P=0.045 and P=0.039). Conclusions:Mitral valvuloplasty is efficacious for congenital mitral valve diseases. However, repairing mitral valves remains a challenge in infants, especially those aged under 1 year. Although some children require multiple reoperations, valvuloplasty is still the most important method of reoperation.

Surgical approaches and mid-term outcomes of congenital mitral valve diseases in children